A case of gait disturbance caused by low-dose gabapentin

4Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Gabapentin, an anticonvulsant agent, is now often used for the treatment of neuropathic pain all over the world. It is unclear whether the combined use of gabapentin, sodium valproate, and flunitrazepam results in enhancement of the side effect, a gait disturbance. A 60-year-old man was taking oral sodium valproate for symptomatic epilepsy after a brain contusion and flunitrazepam to relieve insomnia. Oral gabapentin therapy was started for suspected neuropathic pain. Although the initial dose of oral gabapentin (200 mg) relieved the pain, the lower extremities became weak, resulting in a gait disturbance. The therapy was restarted with a halved dose, and this resolved the gait disturbance and relieved the pain.

Cite

CITATION STYLE

APA

Kanao-Kanda, M., Kanda, H., Takahata, O., & Kunisawa, T. (2016). A case of gait disturbance caused by low-dose gabapentin. Therapeutics and Clinical Risk Management, 12, 927–929. https://doi.org/10.2147/TCRM.S107350

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free